These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32738838)

  • 1. Study of Diversity of Metformin Related Gastrointestinal Side Effects.
    Saluja M; Pareek KK; Swami YK
    J Assoc Physicians India; 2020 Aug; 68(8):36-38. PubMed ID: 32738838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients.
    Siavash M; Tabbakhian M; Sabzghabaee AM; Razavi N
    J Res Pharm Pract; 2017; 6(2):73-76. PubMed ID: 28616428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients.
    Guo L; Guo X; Li Y; Hong X; Jiang X; Su Q; Zhao D; Wu X; Ji L
    Diabetes Metab Syndr; 2016; 10(3):137-42. PubMed ID: 26948203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.
    Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W
    J Clin Pharm Ther; 2015 Aug; 40(4):461-5. PubMed ID: 26032654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron and metformin-induced gastrointestinal side effects.
    Hoffmann IS; Roa M; Torrico F; Cubeddu LX
    Am J Ther; 2003; 10(6):447-51. PubMed ID: 14624284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and overcoming metformin gastrointestinal intolerance.
    Bonnet F; Scheen A
    Diabetes Obes Metab; 2017 Apr; 19(4):473-481. PubMed ID: 27987248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years.
    Chaudhary M; Midha NK; Sukhadiya P; Kumar D; Garg MK
    Cureus; 2024 Mar; 16(3):e56828. PubMed ID: 38654785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.
    Burton JH; Johnson M; Johnson J; Hsia DS; Greenway FL; Heiman ML
    J Diabetes Sci Technol; 2015 Jul; 9(4):808-14. PubMed ID: 25802471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as a cause of late-onset chronic diarrhea.
    Foss MT; Clement KD
    Pharmacotherapy; 2001 Nov; 21(11):1422-4. PubMed ID: 11714216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release.
    Hameed M; Khan K; Salman S; Mehmood N
    J Ayub Med Coll Abbottabad; 2017; 29(2):225-229. PubMed ID: 28718236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes.
    Thong KY; Gupta PS; Blann AD; Ryder RE
    Diabetes Res Clin Pract; 2015 Jul; 109(1):124-9. PubMed ID: 25937541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the phenotype of patients with gastrointestinal intolerance to metformin?
    Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab; 2013 Sep; 39(4):322-9. PubMed ID: 23786968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study.
    Lin YC; Lin LY; Wang HF; Lin HD
    J Chin Med Assoc; 2010 Dec; 73(12):617-22. PubMed ID: 21145508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.
    Derosa G; Salvadeo SA; D'Angelo A; Ferrari I; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    Curr Med Res Opin; 2009 Mar; 25(3):607-15. PubMed ID: 19232035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
    Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
    Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounding Metformin for Use in Functional Medicine.
    Desai S; Thompson T
    Int J Pharm Compd; 2023; 27(5):362-366. PubMed ID: 37816179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.